Q4 2023 · 13F-HR/A
PERCEPTIVE ADVISORS LLCholdings as filed
Filed 2024-02-26 · accession 0001012975-24-000112
$4.48B
Reported value
101
Positions
2023-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 15678U128 | CERE1EUR | CEREVEL THERAPEUTICS HLDNG I | $464.9M | 10.4% | 10,965,193 | Common | SOLE |
| 03152W109 | AM6 | AMICUS THERAPEUTICS INC | $398.1M | 8.89% | 28,057,456 | Common | SOLE |
| 53000N108 | LIANY | LIANBIO | $257.3M | 5.74% | 57,558,451 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $252.2M | 5.63% | 4,544,809 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $214.7M | 4.79% | 2,917,991 | Common | SOLE |
| 45720L107 | INBXUSD | INHIBRX INC | $161.7M | 3.61% | 4,256,104 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $123.8M | 2.76% | 3,074,542 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $99.0M | 2.21% | 2,154,110 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $98.1M | 2.19% | 2,328,082 | Common | SOLE |
| 462260100 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $97.4M | 2.17% | 11,979,415 | Common | SOLE |
| 23257D103 | CBAYUSD | CYMABAY THERAPEUTICS INC | $95.1M | 2.12% | 4,024,400 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $82.6M | 1.84% | 1,038,019 | Common | SOLE |
| G5960L103 | MDT | MEDTRONIC PLC | $80.5M | 1.80% | 976,652 | Common | SOLE |
| 14179K101 | CRGX | CARGO THERAPEUTICS INC | $79.6M | 1.78% | 3,436,600 | Common | SOLE |
| G59665102 | MGTX | MEIRAGTX HLDGS PLC | $79.5M | 1.78% | 11,331,103 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $76.9M | 1.72% | 3,866,214 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $73.8M | 1.65% | 1,725,047 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $71.4M | 1.59% | 1,957,246 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $70.6M | 1.58% | 1,748,933 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $68.4M | 1.53% | 1,088,486 | Common | SOLE |
| 55234L105 | LYRAGBP | LYRA THERAPEUTICS INC | $66.8M | 1.49% | 12,757,562 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $59.1M | 1.32% | 1,023,045 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $56.1M | 1.25% | 2,606,679 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $53.3M | 1.19% | 850,225 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $53.2M | 1.19% | 2,139,950 | Common | SOLE |
| 92511W108 | — | VERRICA PHARMACEUTICALS INC | $52.0M | 1.16% | 7,099,182 | Common | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $51.2M | 1.14% | 1,707,398 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $51.1M | 1.14% | 1,827,901 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $50.7M | 1.13% | 1,100,748 | Common | SOLE |
| 75525N107 | — | RAYZEBIO INC | $46.3M | 1.03% | 744,056 | Common | SOLE |
| 12674W109 | CABA | CABALETTA BIO INC | $45.5M | 1.01% | 2,003,058 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $44.7M | 1.00% | 1,255,512 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $43.6M | 0.97% | 451,873 | Common | SOLE |
| 30052C107 | EOLS | EVOLUS INC | $41.7M | 0.93% | 3,963,424 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $37.7M | 0.84% | 1,730,212 | Common | SOLE |
| 63909J108 | NAUT | NAUTILUS BIOTECHNOLOGY INC | $37.7M | 0.84% | 12,594,211 | Common | SOLE |
| 00287Y109 | ABBV | ABBVIE INC | $36.9M | 0.82% | 238,000 | Common | SOLE |
| N44445109 | IMTX | IMMATICS N.V | $36.8M | 0.82% | 3,491,500 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $35.7M | 0.80% | 270,794 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $35.0M | 0.78% | 151,151 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $30.8M | 0.69% | 4,004,070 | Common | SOLE |
| 01438T106 | ALDX | ALDEYRA THERAPEUTICS INC | $30.2M | 0.67% | 8,593,586 | Common | SOLE |
| 000899104 | ADMA | ADMA BIOLOGICS INC | $29.1M | 0.65% | 6,433,369 | Common | SOLE |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $27.5M | 0.61% | 1,869,125 | Common | SOLE |
| 36118A100 | — | FUSION PHARMACEUTICALS INC | $26.4M | 0.59% | 2,751,395 | Common | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS | $26.3M | 0.59% | 1,296,416 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $23.5M | 0.52% | 818,882 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $22.6M | 0.50% | 967,775 | Common | SOLE |
| 68572M106 | OBIO | ORCHESTRA BIOMED HLDGS INC | $22.2M | 0.50% | 2,432,089 | Common | SOLE |
| 15102K100 | CELC | CELCUITY INC | $21.6M | 0.48% | 1,481,300 | Common | SOLE |
| 83422E204 | SLDB | SOLID BIOSCIENCES INC | $21.5M | 0.48% | 3,495,933 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $18.6M | 0.41% | 55,000 | Common | SOLE |
| 228903100 | AORT | ARTIVION INC | $16.7M | 0.37% | 931,352 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMAA/S | $16.6M | 0.37% | 132,176 | Common | SOLE |
| 89455T109 | TMCI | TREACE MED CONCEPTS INC | $15.9M | 0.36% | 1,250,405 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $15.8M | 0.35% | 534,942 | Common | SOLE |
| 004890109 | ACRV | ACRIVON THERAPEUTICS INC | $14.8M | 0.33% | 3,007,858 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $14.6M | 0.33% | 354,082 | Common | SOLE |
| 03828A101 | APLT | APPLIED THERAPEUTICS INC | $13.7M | 0.31% | 4,080,249 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT PHARMACEUTICALS INC | $13.6M | 0.30% | 589,646 | Common | SOLE |
| 04746L104 | — | ATHIRA PHARMA INC | $13.1M | 0.29% | 5,402,964 | Common | SOLE |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $11.8M | 0.26% | 1,831,167 | Common | SOLE |
| 98985Y108 | ZYME | ZYMEWORKS INC | $11.2M | 0.25% | 1,074,807 | Common | SOLE |
| 87583X109 | TNGX | TANGO THERAPEUTICS INC | $11.0M | 0.25% | 1,111,870 | Common | SOLE |
| 87357P100 | TCMD | TACTILE SYS TECHNOLOGY INC | $10.1M | 0.23% | 707,159 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $8.8M | 0.20% | 383,260 | Common | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $7.7M | 0.17% | 108,000 | Common | SOLE |
| 68062P106 | OLMA | OLEMA PHARMACEUTICALS INC | $7.6M | 0.17% | 539,831 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $7.0M | 0.16% | 1,075,000 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $6.6M | 0.15% | 1,122,958 | Common | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $6.1M | 0.14% | 342,408 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $6.1M | 0.14% | 555,555 | Common | SOLE |
| 556099109 | MGNX | MACROGENICS INC | $5.9M | 0.13% | 611,932 | Common | SOLE |
| 05463X106 | AXGN | AXOGEN INC | $5.5M | 0.12% | 808,380 | Common | SOLE |
| 515069201 | — | LANDOS BIOPHARMA INC | $5.4M | 0.12% | 1,486,991 | Common | SOLE |
| 90240B106 | TYRA | TYRA BIOSCIENCES INC | $5.0M | 0.11% | 360,000 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $5.0M | 0.11% | 82,398 | Common | SOLE |
| 670002401 | NVAX | NOVAVAX INC | $4.8M | 0.11% | 1,400,000 | PUT | SOLE |
| 63009J107 | NBTX | NANOBIOTIX | $4.0M | 0.09% | 555,066 | Common | SOLE |
| 92536C103 | VERUEUR | VERU INC | $4.0M | 0.09% | 5,584,699 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $3.6M | 0.08% | 400,000 | Common | SOLE |
| 29415J106 | — | ENVVENO MEDICAL CORPORATION | $3.2M | 0.07% | 623,315 | Common | SOLE |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $3.2M | 0.07% | 101,000 | Common | SOLE |
| 98420X103 | ASNSUSD | X4 PHARMACEUTICALS INC | $3.0M | 0.07% | 3,545,454 | Common | SOLE |
| 34962G109 | TOCAEUR | FORTE BIOSCIENCES INC | $2.7M | 0.06% | 3,265,359 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $2.5M | 0.06% | 30,317 | Common | SOLE |
| 50107A104 | KRON1USD | KRONOS BIO INC | $2.2M | 0.05% | 1,752,745 | Common | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HLDGS INC | $2.1M | 0.05% | 82,299 | Common | SOLE |
| 14171W103 | — | CAREMAX INC | $1.8M | 0.04% | 3,679,284 | Common | SOLE |
| 61775R105 | MORFUSD | MORPHIC HLDGS INC | $1.6M | 0.04% | 56,980 | Common | SOLE |
| 78464A870 | XBI | SPDR SER TR | $1.3M | 0.03% | 1,900,000 | PUT | SOLE |
| 641871108 | — | AMBRX BIOPHARMA INC | $1.1M | 0.03% | 78,811 | Common | SOLE |
| 82933R100 | — | SINGULAR GENOMICS SYSTEMS IN | $978,583 | 0.02% | 2,126,893 | Common | SOLE |
| 91822J202 | LO9A | VBI VACCINES INC CDA | $814,999 | 0.02% | 1,381,355 | Common | SOLE |
| 03828A101 | APLT | APPLIED THERAPEUTICS INC | $500,000 | 0.01% | 500,000 | CALL | SOLE |
| 52187K200 | CYPH | LEAP THERAPEUTICS INC | $186,404 | 0.00% | 44,971 | Common | SOLE |
| 09077B104 | BCABGBP | BIOATLA INC | $179,580 | 0.00% | 73,000 | Common | SOLE |
| 76155X118 | RVMDW | REVOLUTION MEDICINES INC | $82,500 | 0.00% | 250,000 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT PHARMACEUTICALS INC | $37,500 | 0.00% | 750,000 | PUT | SOLE |
| 86889P117 | SRZNW | SURROZEN INC | $3,333 | 0.00% | 166,666 | Common | SOLE |
| 14171W111 | — | CAREMAX INC | $450 | 0.00% | 60,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.